Anagnostics Announces European Collaboration with Sony DADC

Anagnostics has announced that it is to collaborate with Sony DADC to develop and produce its revolutionary hybcell tests. The agreement promises to enhance the effectiveness of the laboratory tests and advance the integration and automation of their production.

Sony DADC BioSciences is a worldwide leader in the development and production of plastic consumables and technical coatings used in medical technology. Under the agreement, Sony DADC will initially be in charge of the die-casting of plastic parts and their functional coating with the objective of further enhancing the performance of the components. This sets a European precedent for Sony DADC collaborations which up until now have traditionally been dominated by American diagnostics companies.

“Medical technology and especially laboratory diagnostics is an important future market for Sony DADC. Innovative companies like Anagnostics have recognized the trend toward the multiplex diagnostics and will therefore prevail in the market. We are pleased to be collaborating with Anagnostics, particularly since they are so ‘local’ to us in Austria” says Dr. Georg Bauer, Director Engineering BioSciences of Sony DADC. Looking forward beyond the current production project, plans are in place to integrate production in the future. “With Agnagnostics focusing on developing testing systems and sales, we are of course considering strategies for significantly scaling up production in an efficient way. With their comprehensive experience in the mass production of biotech components, Sony DADC is a very helpful partner to have”, adds Reschreiter.

Mag. Christoph Reschreiter, CEO Anagnostics Bioanalysis GmbH comments “The extremely high standard Sony DADC demand of themselves, their experience in the field of medical technology and especially their innovativeness regarding plastics and surface technology convinced us that we have found the right partner in Sony DADC for expanding our production”.